2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Circana
Category
Corporate Identity - Corporate Identity Redesign (NEW)
Country / Region
United States
Entrant Company
Faktory
Category
Video - Medical
Country / Region
United States
Entrant Company
PRISM DESIGN STUDIO
Category
Outdoor Advertising - Signage
Country / Region
China
Entrant Company
80's Creative
Category
Video - Cinematography
Country / Region
Saudi Arabia